Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MERCK & CO., INC.

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Merck : Price Target From RBC Cut to $75 From $77 to Reflect Organon Spinoff, Sector Perform Maintained

06/08/2021 | 09:01am EDT


© MT Newswires 2021
All news about MERCK & CO., INC.
10:57aSILVERBACK THERAPEUTICS : Reports Early Data From Phase 1/1b Study of SBT6050 in..
MT
10:27aHOOKIPA PHARMA : announces clinical collaboration with Merck & Co., Inc., Kenilw..
AQ
07:34aBIOXCEL THERAPEUTICS : Says Therapeutics Study Shows Anti-Tumor Activity of Pros..
MT
01:30aBIOCORP and MERCK Sign a Partnership in the Field of Human Growth Hormone
CI
09/15HOOKIPA PHARMA : Merck Collaborate on Head, Neck Cancer Combo Therapy Developmen..
MT
09/15HOOKIPA Pharma Inc. Announces Clinical Collaboration with Merck & Co., Inc., ..
CI
09/15Hookipa Working With Merck in Advanced Head and Neck Cancers
DJ
09/14IO Biotech Announces Clinical Collaboration with MSD to Evaluate IO102-IO103 ..
CI
09/14MERCK & CO., INC. : Ex-dividend day for
FA
09/13Merck sees potential U.S. authorization for COVID-19 antiviral before year-en..
RE
More news
Analyst Recommendations on MERCK & CO., INC.
More recommendations
Financials (USD)
Sales 2021 46 894 M - -
Net income 2021 12 645 M - -
Net Debt 2021 15 254 M - -
P/E ratio 2021 15,9x
Yield 2021 3,56%
Capitalization 184 B 184 B -
EV / Sales 2021 4,26x
EV / Sales 2022 3,85x
Nbr of Employees 73 500
Free-Float 70,7%
Chart MERCK & CO., INC.
Duration : Period :
Merck & Co., Inc. Technical Analysis Chart | MRK | US58933Y1055 | MarketScreener
Technical analysis trends MERCK & CO., INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 22
Last Close Price 72,81 $
Average target price 94,61 $
Spread / Average Target 29,9%
EPS Revisions
Managers and Directors
Robert M. Davis President, Chief Executive Officer & Director
Caroline A. Litchfield Chief Financial Officer & Executive Vice President
Kenneth C. Frazier Executive Chairman
Sandy Tremps Vice President-R&D IT CIO
Dave Williams Chief Information & Digital Officer
Sector and Competitors
1st jan.Capi. (M$)
MERCK & CO., INC.-10.99%184 309
JOHNSON & JOHNSON5.11%435 465
ROCHE HOLDING AG11.23%327 497
PFIZER, INC.21.46%251 011
NOVO NORDISK A/S49.16%231 607
ELI LILLY AND COMPANY38.43%211 895